Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis
Minhong Shen(Fudan University Shanghai Cancer Center), Yibin Kang(Rutgers, The State University of New Jersey), Sven Michel(Hikma Pharmaceuticals (Germany)), Michelle Rowicki(Princeton University), Shanshan Xie(Henan Agricultural University), Frank Jaschinski(Hikma Pharmaceuticals (Germany)), John F. Jin, Yong Wei(The Ohio State University), Min Yuan(Tongji University), Tianhua Zhou(Hunan Normal University), Liling Wan(University of Pennsylvania), Richard Klar(Hikma Pharmaceuticals (Germany)), Xiang Hang(Christian-Albrechts-Universität zu Kiel), Xin Lü(University of Notre Dame)
Cited by 53
Related Papers
Tumour exosome integrins determine organotropic metastasis
|Nature|2015|5.2k
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
|Nature Medicine|2012|3.7k
A multigenic program mediating breast cancer metastasis to bone
|Cancer Cell|2003|2.6k
Guidelines and definitions for research on epithelial–mesenchymal transition
|Nature Reviews Molecular Cell Biology|2020|2.3k
Pre-metastatic niches: organ-specific homes for metastases
|Nature reviews. Cancer|2017|1.9k